Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.070
-0.090 (-7.76%)
At close: Jun 5, 2026, 4:00 PM EDT
1.100
+0.029 (2.76%)
After-hours: Jun 5, 2026, 7:59 PM EDT

Inovio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-84.93-84.95-107.25-135.12-279.82-303.66
Depreciation & Amortization
2.992.993.133.55.54.73
Stock-Based Compensation
3.063.766.611.0722.5626.34
Other Adjustments
1.15-1.21-3.886.4415.726.53
Change in Receivables
0.04--9.33-3.7111.03
Changes in Accounts Payable
-4.12-6.42-3.48-45.9932.6126.14
Changes in Accrued Expenses
-1-1.37-0.34-8.230.270.38
Changes in Unearned Revenue
-----0.09-0.04
Changes in Other Operating Activities
-0.89-1.421.1634.63-9.2512.84
Operating Cash Flow
-83.35-88.63-104.08-124.37-216.22-215.71
Capital Expenditures
-0.23-0.29-0.49-0.32-0.97-1.23
Sale of Property, Plant & Equipment
--0.066.22--
Purchases of Investments
-7.92-4.95-54.14-203.48-248.53-348.95
Proceeds from Sale of Investments
19.6819.27158.64284.93361.08174.84
Other Investing Activities
-----2-
Investing Cash Flow
16.7314.04104.0787.36109.59-175.34
Long-Term Debt Repaid
---16.42---
Net Long-Term Debt Issued (Repaid)
---16.42---
Issuance of Common Stock
35.453.1668.315.4683.24216.11
Repurchase of Common Stock
-0.17-0.11-0.42-0.47-1.4-4.61
Net Common Stock Issued (Repurchased)
35.2453.0567.89581.84211.5
Financing Cash Flow
52.9853.0551.48581.84211.5
Effect of Exchange Rate Changes on Cash and Cash Equivalents
--0.03-0-0.03-0.03
Net Cash Flow
-13.64-21.5451.5-32.02-24.81-179.58
Free Cash Flow
-83.57-88.92-104.56-124.69-217.19-216.94
FCF Margin
--136074.00%-48019.10%-14986.20%-2116.34%-12223.60%
Free Cash Flow Per Share
-1.50-1.90-3.85-5.62-10.92-12.47
Levered Free Cash Flow
-88.18-91.46-123.69-151.53-251.75-260.84
Unlevered Free Cash Flow
-86.97-93.34-112.42-160.35-239.51-258.4
SEC Filings: 10-K · 10-Q